Literature DB >> 8458774

Effects of naloxone on the sensation of dyspnea during acute respiratory stress in normal adults.

Y Akiyama1, M Nishimura, S Kobayashi, A Yoshioka, M Yamamoto, K Miyamoto, Y Kawakami.   

Abstract

To clarify whether endogenous opioids modulate the dyspnea intensity and, if so, by what mechanism they act on it, we examined 12 healthy male volunteers aged 19-27 yr for ventilatory and peak mouth pressure (Pm) responses to hypoxic progressive hypercapnia with inspiratory flow-resistive loading after the intravenous infusion of 3 mg of naloxone or saline. The intensity of dyspnea was simultaneously assessed by visual analogue scaling every 15 s. Naloxone administration increased both ventilatory and Pm responses to hypoxic progressive hypercapnia (P < 0.05 for both). The increase in dyspnea intensity for a given increase in end-tidal PCO2 was significantly greater after naloxone infusion than after saline (P < 0.05). However, there were no differences in the increase in dyspnea intensity for a given increase in minute ventilation or Pm. These results suggest that the endogenous opioid system suppresses the respiratory output under a strong, acute respiratory stress in normal adults and that this system may relieve the dyspnea sensation secondary to the suppression of the brain stem respiratory center without specific effects on the processing of respiratory sensations in the higher brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458774     DOI: 10.1152/jappl.1993.74.2.590

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

Review 2.  The symptomatic relief of dyspnea.

Authors:  Giovanni Elia; Jay Thomas
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

3.  Opioid depression of respiration in neonatal rats.

Authors:  J J Greer; J E Carter; Z al-Zubaidy
Journal:  J Physiol       Date:  1995-06-15       Impact factor: 5.182

4.  Order-preserving dimension reduction procedure for the dominance of two mean curves with application to tidal volume curves.

Authors:  Sang Han Lee; Johan Lim; Marina Vannucci; Eva Petkova; Maurice Preter; Donald F Klein
Journal:  Biometrics       Date:  2007-12-31       Impact factor: 1.701

Review 5.  A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder.

Authors:  Ashton E Clark; Shelby R Goodwin; Russell M Marks; Annabelle M Belcher; Emily Heinlein; Melanie E Bennett; Daniel J O Roche
Journal:  J Dual Diagn       Date:  2021-09-28

6.  Control and sensation of breathing during cycling exercise in hypoxia under naloxone: a randomised controlled crossover trial.

Authors:  Laurent Koglin; Bengt Kayser
Journal:  Extrem Physiol Med       Date:  2013-01-02

7.  Interactions Between Dyspnea and the Brain Processing of Nociceptive Stimuli: Experimental Air Hunger Attenuates Laser-Evoked Brain Potentials in Humans.

Authors:  Laurence Dangers; Louis Laviolette; Thomas Similowski; Capucine Morélot-Panzini
Journal:  Front Physiol       Date:  2015-12-01       Impact factor: 4.566

Review 8.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.